U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds
The cost of insulin for treating Type 1 diabetes in the United States nearly doubled over a recent five-year period, underscoring a national outcry over rising drug prices, according to a new analysis.
A patient with Type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that, at $2,864 per patient, in 2012, according to a report released on Tuesday by the nonprofit Health Care Cost Institute.
The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.
(Score: 2) by dry on Thursday January 24 2019, @05:00PM (1 child)
And under private insurance, the private company decides what treatments are available. As private industry is usually more inefficient due to needing to make a profit and pay its executives bonuses and golden parachutes, the government by default is a better choice. If you disagree, well you do have the choice of private.
(Score: 0) by Anonymous Coward on Thursday January 24 2019, @06:30PM
Oh yea. Health insurance is a huge scam. It is much cheaper not to use it. I would like to get a really high deductible plan for really cheap. I mean like a couple hundred dollars/year with a $20-100k deductible, but that doesn't exist because it would make too much sense.